Evolus (EOLS) Short Interest Ratio & Short Volume $9.87 +0.22 (+2.28%) Closing price 04:00 PM EasternExtended Trading$10.07 +0.21 (+2.08%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Evolus Short Interest DataEvolus (EOLS) has a short interest of 9.24 million shares, representing 15.54% of the float (the number of shares available for trading by the public). This marks a 5.72% increase in short interest from the previous month. The short interest ratio (days to cover) is 10.3, indicating that it would take 10.3 days of the average trading volume of 730,569 shares to cover all short positions.Current Short Interest9,240,000 sharesPrevious Short Interest8,740,000 sharesChange Vs. Previous Month+5.72%Dollar Volume Sold Short$92.40 millionShort Interest Ratio10.3 Days to CoverLast Record DateMay 15, 2025Outstanding Shares64,476,000 sharesShort Percent of Float15.54%Today's Trading Volume953,439 sharesAverage Trading Volume730,569 sharesToday's Volume Vs. Average131% Short Selling Evolus? Sign up to receive the latest short interest report for Evolus and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEOLS Short Interest Over TimeEOLS Days to Cover Over TimeEOLS Percentage of Float Shorted Over Time Evolus Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20259,240,000 shares $92.40 million +5.7%15.5%10.3 $10.00 4/30/20258,740,000 shares $99.64 million +14.0%N/A10 $11.40 4/15/20257,670,000 shares $78.46 million +7.3%12.9%9.1 $10.23 3/31/20257,150,000 shares $86.01 million +1.4%12.0%8.5 $12.03 3/15/20257,050,000 shares $93.06 million +3.5%11.9%9 $13.20 2/28/20256,810,000 shares $99.36 million +3.8%11.5%9 $14.59 2/15/20256,560,000 shares $96.69 million +9.5%11.0%9.1 $14.74 1/31/20255,990,000 shares $83.68 million +1.0%N/A8 $13.97 1/15/20255,930,000 shares $59.72 million +9.8%N/A8.8 $10.07 12/31/20245,400,000 shares $59.62 million +4.3%N/A8.6 $11.04 Get the Latest News and Ratings for EOLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evolus and its competitors with MarketBeat's FREE daily newsletter. 12/15/20245,180,000 shares $59.62 million -0.6%N/A8.6 $11.51 11/30/20245,210,000 shares $71.32 million -1.5%N/A8.2 $13.69 11/15/20245,290,000 shares $64.06 million -2.6%N/A8.4 $12.11 10/31/20245,430,000 shares $88.62 million +8.8%N/A8.9 $16.32 10/15/20244,990,000 shares $83.33 million +3.1%N/A8.5 $16.70 9/30/20244,840,000 shares $78.41 million -0.8%N/A8.8 $16.20 9/15/20244,880,000 shares $85.35 million +2.3%N/A9 $17.49 8/31/20244,770,000 shares $75.80 million -1.0%N/A9.5 $15.89 8/15/20244,820,000 shares $65.55 million -4.4%N/A9.6 $13.60 7/31/20245,040,000 shares $62.60 million -4.0%N/A9.8 $12.42 7/15/20245,250,000 shares $63.37 million +10.5%9.7%9.8 $12.07 6/30/20244,750,000 shares $51.54 million +4.6%8.8%8.7 $10.85 6/15/20244,540,000 shares $51.44 million +2.0%8.4%8.3 $11.33 5/31/20244,450,000 shares $57.54 million -4.1%8.3%7.7 $12.93 5/15/20244,640,000 shares $61.43 million -2.9%8.6%7.4 $13.24 4/30/20244,780,000 shares $56.26 million +3.0%9.7%7.7 $11.77 4/15/20244,640,000 shares $55.17 million -0.2%9.6%8.1 $11.89 3/31/20244,650,000 shares $65.10 million -6.6%9.8%7.1 $14.00 3/15/20244,980,000 shares $69.22 million +0.4%10.5%7.7 $13.90 2/29/20244,960,000 shares $73.56 million +1.2%11.3%8.2 $14.83 2/15/20244,900,000 shares $67.47 million +2.9%11.1%8.1 $13.77 1/31/20244,760,000 shares $60.40 million +17.2%10.8%6.6 $12.69 1/15/20244,060,000 shares $42.83 million -7.3%9.2%5.4 $10.55 12/31/20234,380,000 shares $46.12 million -1.1%9.9%6.3 $10.53 12/15/20234,430,000 shares $43.86 million -9.0%10.0%6.5 $9.90 11/30/20234,870,000 shares $46.12 million -25.4%11.0%7.3 $9.47 11/15/20236,530,000 shares $58.18 million +60.8%14.8%10.2 $8.91 10/31/20234,060,000 shares $30.86 million +4.4%9.2%7.1 $7.60 10/15/20233,890,000 shares $31.66 million +1.3%8.8%6.5 $8.14 9/30/20233,840,000 shares $35.10 million +7.9%9.1%7.1 $9.14The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.This little-known company holds nearly 100 patents and trades for around $7 9/15/20233,560,000 shares $33.61 million +5.3%8.4%6.2 $9.44 8/31/20233,380,000 shares $33.43 million -0.6%8.0%5.1 $9.89 8/15/20233,400,000 shares $34.68 million -21.7%8.1%5 $10.20 7/31/20234,340,000 shares $43.49 million -1.6%10.1%6.2 $10.02 7/15/20234,410,000 shares $32.63 million +24.6%10.3%7.8 $7.40 6/30/20233,540,000 shares $25.74 million +17.6%8.3%6.1 $7.27 6/15/20233,010,000 shares $23.15 million +7.1%7.1%5.6 $7.69 5/31/20232,810,000 shares $25.43 million -0.4%6.6%5.6 $9.05 5/15/20232,820,000 shares $29.10 million +2.2%6.6%6.4 $10.32 4/30/20232,760,000 shares $24.12 million +9.5%6.6%5.4 $8.74 4/15/20232,520,000 shares $21.14 million +4.1%6.0%4.8 $8.39 3/31/20232,420,000 shares $20.47 million +10.5%5.8%4.6 $8.46 3/15/20232,190,000 shares $18.75 million -0.9%5.2%4.1 $8.56 2/28/20232,210,000 shares $20.04 million -6.4%5.4%4.2 $9.07 2/15/20232,360,000 shares $22.11 million +6.3%5.8%4.5 $9.37 1/31/20232,220,000 shares $23.07 million -14.3%6.1%4.6 $10.39 1/15/20232,590,000 shares $22.40 million +0.4%7.0%6.2 $8.65 12/30/20222,580,000 shares $19.38 million +33.7%7.0%6.7 $7.51 12/15/20221,930,000 shares $13.55 million -15.4%5.2%4.8 $7.02 11/30/20222,280,000 shares $16.51 million -2.6%6.2%5.7 $7.24 11/15/20222,340,000 shares $17.64 million -8.2%6.3%5.7 $7.54 10/31/20222,550,000 shares $21.83 million -5.2%6.9%5.7 $8.56 10/15/20222,690,000 shares $22.41 million +24.0%7.3%5.2 $8.33 9/30/20222,170,000 shares $17.47 million +11.3%5.9%4.1 $8.05 9/15/20221,950,000 shares $19.81 million -5.3%5.3%3.9 $10.16 8/31/20222,060,000 shares $19.80 million -3.7%5.7%3.9 $9.61 8/15/20222,140,000 shares $20.24 million +6.5%6.0%4 $9.46 7/31/20222,010,000 shares $24.78 million -7.4%5.6%3.4 $12.33 7/15/20222,170,000 shares $27.80 million -8.1%6.1%4.3 $12.81 6/30/20222,360,000 shares $27.38 million -8.2%6.6%4.7 $11.60 6/15/20222,570,000 shares $30.40 million -13.2%7.2%5.1 $11.83 5/31/20222,960,000 shares $38.18 million -2.6%8.3%5.8 $12.90 5/15/20223,040,000 shares $40.07 million +22.1%8.5%6.2 $13.18 4/30/20222,490,000 shares $27.86 million +9.2%7.0%5.5 $11.19 4/15/20222,280,000 shares $25.72 million -1.7%6.4%4.7 $11.28 3/31/20222,320,000 shares $26.03 million -7.2%6.6%4.7 $11.22 3/15/20222,500,000 shares $24.88 million +4.2%7.1%5 $9.95 2/28/20222,400,000 shares $21.96 million -4.4%6.8%5 $9.15 2/15/20222,510,000 shares $22.82 million -12.5%7.1%5.1 $9.09 1/31/20222,870,000 shares $21.30 million +6.7%8.2%5.9 $7.42 1/15/20222,690,000 shares $15.47 million +3.5%N/A0 $5.75 12/31/20212,600,000 shares $16.93 million +12.1%7.2%6 $6.51 12/15/20212,320,000 shares $13.48 million +7.9%6.4%4.8 $5.81 11/30/20212,150,000 shares $11.91 million +1.9%6.0%4.3 $5.54 11/15/20212,110,000 shares $14.98 million -4.5%5.9%4.1 $7.10 10/29/20212,210,000 shares $17.28 million -11.6%6.1%4.2 $7.82 10/15/20212,500,000 shares $19.18 million +4.6%7.1%4.7 $7.67 9/30/20212,390,000 shares $18.21 million -1.2%6.8%4.6 $7.62 9/15/20212,420,000 shares $19.60 million -3.6%6.8%4.6 $8.10 8/31/20212,510,000 shares $26.61 million -21.6%7.7%4.7 $10.60The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.This little-known company holds nearly 100 patents and trades for around $7 8/13/20213,200,000 shares $33.92 million -10.4%9.7%6.3 $10.60 7/30/20213,570,000 shares $38.63 million +1.7%10.7%6.4 $10.82 7/15/20213,510,000 shares $40.61 million +9.7%10.6%5.4 $11.57 6/30/20213,200,000 shares $40.48 million +13.1%9.7%4.1 $12.65 6/15/20212,830,000 shares $33.56 million -5.0%8.6%3.1 $11.86 5/28/20212,980,000 shares $32.24 million -19.9%9.0%3.1 $10.82 5/14/20213,720,000 shares $32.22 million +10.7%N/A3.4 $8.66 4/30/20213,360,000 shares $30.68 million -8.7%N/A2 $9.13 4/15/20213,680,000 shares $43.13 million +22.7%17.4%2.2 $11.72 3/31/20213,000,000 shares $35.25 million +2.0%15.5%1.9 $11.75 3/15/20212,940,000 shares $39.25 million -8.1%16.7%2 $13.35 2/26/20213,200,000 shares $36.80 million -3.3%22.4%2.1 $11.50 2/12/20213,310,000 shares $23.30 million -9.6%15.6%2.3 $7.04 1/29/20213,660,000 shares $23.94 million -11.4%17.2%4.6 $6.54 1/15/20214,130,000 shares $23.33 million +5.9%18.9%5.4 $5.65 12/31/20203,900,000 shares $13.26 million +5.1%17.8%6.1 $3.40 12/15/20203,710,000 shares $14.36 million -6.8%16.9%6.3 $3.87 11/30/20203,980,000 shares $15.24 million -0.5%18.2%9 $3.83 11/15/20204,000,000 shares $14.08 million +6.7%18.3%8.7 $3.52 10/30/20203,750,000 shares $10.95 million +8.7%17.1%8.9 $2.92 10/15/20203,450,000 shares $14.84 million +0.6%15.7%7.7 $4.30 9/30/20203,430,000 shares $13.41 million -15.3%15.6%0 $3.91 9/15/20204,050,000 shares $14.82 million -6.9%18.5%5.6 $3.66 8/31/20204,350,000 shares $16.79 million -6.7%19.8%5.8 $3.86 8/14/20204,660,000 shares $17.34 million -7.4%21.2%5 $3.72 7/31/20205,030,000 shares $16.40 million -4.2%22.9%4.4 $3.26 7/15/20205,250,000 shares $16.54 million -4.0%23.9%4.7 $3.15 6/30/20205,470,000 shares $28.99 million +9.4%24.9%5.1 $5.30 6/15/20205,000,000 shares $25.40 million +14.7%22.8%5.7 $5.08 EOLS Short Interest - Frequently Asked Questions What is Evolus' current short interest? Short interest is the volume of Evolus shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 9,240,000 shares of EOLS short. 15.54% of Evolus' shares are currently sold short. Learn More on Evolus' current short interest. What is a good short interest ratio for Evolus? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EOLS shares currently have a short interest ratio of 10.0. Learn More on Evolus's short interest ratio. Which institutional investors are shorting Evolus? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Evolus: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Evolus? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 15.54% of Evolus' floating shares are currently sold short. Is Evolus' short interest increasing or decreasing? Evolus saw a increase in short interest in May. As of May 15th, there was short interest totaling 9,240,000 shares, an increase of 5.7% from the previous total of 8,740,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Evolus' short interest compare to its competitors? 15.54% of Evolus' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Evolus: Lyell Immunopharma, Inc. (8.07%), Apellis Pharmaceuticals, Inc. (23.50%), Organon & Co. (6.16%), HUTCHMED (China) Limited (0.26%), ImmunityBio, Inc. (63.75%), Amneal Pharmaceuticals, Inc. (3.73%), Xenon Pharmaceuticals Inc. (4.82%), Mirum Pharmaceuticals, Inc. (16.99%), Arrowhead Pharmaceuticals, Inc. (10.97%), NewAmsterdam Pharma (10.76%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks. What does it mean to sell short Evolus stock? Short selling EOLS is an investing strategy that aims to generate trading profit from Evolus as its price is falling. EOLS shares are trading up $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evolus? A short squeeze for Evolus occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EOLS, which in turn drives the price of the stock up even further. How often is Evolus' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EOLS, twice per month. The most recent reporting period available is May, 15 2025. More Short Interest Resources from MarketBeat Related Companies Apellis Pharmaceuticals Short Squeeze Xenon Pharmaceuticals Short Squeeze Amneal Pharmaceuticals Short Squeeze Mirum Pharmaceuticals Short Squeeze Arrowhead Pharmaceuticals Short Squeeze NewAmsterdam Pharma Short Squeeze Kiniksa Pharmaceuticals Short Squeeze Vericel Short Squeeze Recursion Pharmaceuticals Short Squeeze Denali Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EOLS) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump Nominates “Next Elon”Elon's Replacement? You've been told Elon Musk has been forced out of DC. But did you know his successor ha...Altimetry | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
